Elena Galvani

1.6k citations
38 papers · 1.0k indexed · h-index 16
Topics
Lung Cancer Treatments and Mutations (16 papers)HER2/EGFR in Cancer Research (10 papers)CAR-T cell therapy research (7 papers)

In The Last Decade

Elena Galvani

34 papers receiving 1.0k citations

Peers

Elena Galvani
Comparison fields: 5 of 90
  • Oncology 585
  • Molecular Biology 459
  • Cancer Research 290
  • Pulmonary and Respiratory Medicine 276
  • Immunology 199
Replace Stacey M. Bagby with:
Stacey M. Bagby United States
Charles Pottier Belgium
Weiliang Zhu China
Miriam Redrado Spain
Chris Womack United Kingdom
B. Helfrich United States
Ashiq Masood United States
Nadia Barraco Italy
Justine Y. Bruce United States
Luka Milas United States
Elena Galvani relative to Stacey M. Bagby United States Stacey M. Bagby's profile →
Citations per field
00.5×
Stacey M. Bagby · 1×
Citations per year

Countries citing papers authored by Elena Galvani

Since Specialization
Citations

This map shows the geographic impact of Elena Galvani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Galvani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Galvani more than expected).

Fields of papers citing papers by Elena Galvani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Galvani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Galvani. The network helps show where Elena Galvani may publish in the future.

Co-authorship network of co-authors of Elena Galvani

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Galvani. A scholar is included among the top collaborators of Elena Galvani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Galvani. Elena Galvani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 6
3 8
4 1
5 116
6 144
7 3
8 116
9 4
10 1
11 13
12 10
13 69
14 46
15 80
16 81
17 1
18 38
19 0
20 37

About Elena Galvani

Elena Galvani is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 38 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), HER2/EGFR in Cancer Research (10 papers) and CAR-T cell therapy research (7 papers). The work is most often cited by research in Oncology (585 citations), Cancer Research (290 citations) and Immunology (199 citations). Elena Galvani has collaborated with scholars based in Italy, United Kingdom and Netherlands. Frequent co-authors include Elisa Giovannetti, Godefridus J. Peters, Richard Marais, Piyushkumar A. Mundra, Paul Lorigan, Sara Valpione, Roberta Alfieri, Pier Giorgio Petronini, Andrea Cavazzoni and John Weightman. Their work appears in journals such as Nature Communications, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026